Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 21, 2026
TickeronGET DAILY SIGNALS
EFA vs JIRE: Weighing Passive Tracking Against Active Research in Developed Markets

EFA vs JIRE: Weighing Passive Tracking Against Active Research in Developed Markets

Key Takeaways

  • Passive versus active: EFA is a passive, market-capitalization-weighted tracker of the MSCI EAFE Index, while JIRE is an actively managed, research-enhanced fund that seeks to outperform the same benchmark.
  • Holdings breadth: EFA holds roughly 700 developed-market stocks, whereas JIRE concentrates exposure into about 220 names, creating a more conviction-driven portfolio.
  • Cost advantage: JIRE carries a net expense ratio of 0.24%, slightly below EFA's 0.32% — an edge that compounds over long holding periods.
  • Similar risk profile: Both funds sit in the Foreign Large Blend category, with financials, industrials, and technology among the largest sector weights and Japan and the United Kingdom as top country exposures.
  • Relative positioning: JIRE tilts toward quality names the manager views as mispriced, while EFA offers broader, more mechanical diversification across 21 developed markets.
  • Tickeron AI Verdict: JIRE — its lower cost, active enhancement aimed at the same index, and concentrated quality bias give it a modest structural edge in the current environment.

Why International Developed Markets Are Worth Watching

International developed-market exposure is back in focus as investors reassess valuation gaps, currency dynamics, and earnings momentum outside the United States. These two funds invite a direct ETF comparison because they draw from the same universe — developed markets in Europe, Australasia, and the Far East — yet pursue it through fundamentally different approaches. EFA, the iShares MSCI EAFE ETF, is the benchmark-standard passive vehicle, while JIRE, the JPMorgan International Research Enhanced Equity ETF, is an active fund explicitly designed to beat that same index. Understanding their structural differences in sector exposure, cost, and portfolio construction is essential for investors weighing broad diversification against a more concentrated, research-driven strategy. To compare their profiles side by side, I also checked this using Tickeron’s AI Screener.

Overview of the iShares MSCI EAFE ETF (EFA)

EFA tracks the MSCI EAFE Index, a widely followed benchmark of large- and mid-capitalization equities across developed markets outside the United States and Canada. It is a passive, market-capitalization-weighted fund, meaning a company's weight rises and falls with its total market value rather than any manager's conviction. The portfolio holds roughly 700 securities, providing broad diversification across approximately 21 developed countries, with Japan, the United Kingdom, France, Germany, and Switzerland among the largest country weights.

Top holdings typically include ASML Holding, HSBC Holdings, Roche Holding, Shell, Novartis, AstraZeneca, Nestlé, Siemens, and BHP Group, though no single position dominates given the fund's wide breadth. On a sector allocation basis, financials are the largest weight at roughly 24–26%, followed by industrials near 19%, information technology around 11%, health care near 10%, and consumer discretionary near 8%. EFA carries a net expense ratio of 0.32% and is one of the most liquid international equity ETFs, with a substantial asset base exceeding $75 billion. Its distinguishing feature is pure, transparent benchmark replication with no active bets.

Overview of the JPMorgan International Research Enhanced Equity ETF (JIRE)

JIRE is an actively managed ETF that seeks long-term capital appreciation while attempting to outperform the MSCI EAFE Index over time — maintaining similar sector and geographic risk characteristics to that benchmark. Rather than replicating the index, JPMorgan's managers use fundamental research to overweight companies they consider attractively valued relative to their quality and growth prospects. The portfolio is far more concentrated, holding roughly 220 securities, and may include a limited number of names outside the index.

Its largest positions tend to overlap with EFA's leaders — ASML Holding, AstraZeneca, Shell, Siemens, Allianz, Roche Holding, Nestlé, and Banco Santander — but with meaningfully larger single-name weights that reflect active conviction. Sector allocation is broadly similar to the benchmark, with financials near 26%, industrials near 17%, technology around 12%, health care near 11%, and consumer cyclical near 8%. JIRE's net expense ratio of 0.24% is notably lower than EFA's, and the fund holds roughly $10–11 billion in assets. Although the ETF structure launched in 2022, its strategy traces back to a mutual fund first offered in 1992.

Industry and Thematic Backdrop

Both funds are shaped by the same macro forces affecting developed international equities. Currency fluctuations between the U.S. dollar, euro, yen, and pound directly influence returns for U.S.-based investors. Interest-rate trajectories at the European Central Bank and Bank of Japan remain central drivers, particularly for financials — the largest sector weight in both portfolios — where lending margins are sensitive to policy rates. Europe's semiconductor and industrial exporters, led by companies such as ASML and Siemens, remain tied to global technology and capital-spending cycles, while energy and materials names such as Shell and BHP Group respond to commodity prices and geopolitical supply dynamics. Meanwhile, Japan's corporate governance reforms and the United Kingdom's valuation discount have drawn renewed capital flows into developed international markets, supporting both funds' geographic tilts.

Performance and Positioning Comparison

Across recent market cycles, EFA and JIRE have generally moved in tandem, reflecting their shared benchmark and overlapping top holdings. The key differentiator is relative positioning: EFA's performance is effectively the index itself, delivering broad, mechanical exposure with no active deviation. JIRE, by contrast, can diverge modestly as its managers tilt toward names they view as undervalued or higher quality, concentrating risk into a smaller set of positions. This structure can amplify relative returns during periods when value and quality leadership aligns with the manager's picks, while introducing modest active risk versus the benchmark. Cost is another durable factor — JIRE's 0.24% expense ratio versus EFA's 0.32% gives the active fund a small annual head start. Volatility profiles are similar, though JIRE's higher single-name concentration can produce slightly wider relative swings during sector rotations and earnings cycles among its largest holdings.

Enhancing My ETF Analysis with Tickeron Tools

In my regular research workflow, Tickeron’s AI Screener helps me quickly filter ETFs and stocks by technical patterns, fundamentals, and performance metrics. It surfaces ideas that would otherwise take far longer to identify manually, allowing me to cross-check holdings overlap and sector tilts between funds like these more efficiently.

Tickeron AI Verdict

Based on observable structural characteristics, Tickeron's AI would likely favor JIRE in this comparison. The fund offers a lower expense ratio, a similar sector and geographic risk profile to the benchmark, and an actively managed mandate explicitly designed to outperform the MSCI EAFE Index over time. Its concentrated, research-driven portfolio tilts toward large, liquid, quality names that overlap with EFA's leaders but carry larger weights, potentially capturing stronger returns when those holdings lead. While EFA remains the superior choice for investors seeking maximum diversification and mechanical index purity, JIRE's combination of cost efficiency, active enhancement, and trend-consistent exposure to developed-market leaders gives it a modest probabilistic edge in the current environment. This assessment is analytical in nature and not personalized investment advice.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EFA, JIRE

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


EFA sees MACD Histogram crosses below signal line

EFA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFA as a result. In 63 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

EFA moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

EFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Spotify Technology SA (NYSE:SPOT), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Nokia Corp (NYSE:NOK), Nebius Group N.V. (NASDAQ:NBIS).

Industry description

The investment seeks to track the investment results of the MSCI EAFE Index composed of large- and mid-capitalization developed market equities, excluding the U.S. and Canada. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted, market capitalization-weighted index designed to measure large- and mid-capitalization equity market performance of developed markets outside of the U.S. and Canada.

Market Cap

The average market capitalization across the iShares MSCI EAFE ETF (EFA) ETF is 47.28B. The market cap for tickers in the group ranges from 439.99M to 123.97B. SPOT holds the highest valuation in this group at 123.97B. The lowest valued company is HKD at 439.99M.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was -8%. For the same ETF, the average monthly price growth was -8%, and the average quarterly price growth was -6%. CHKP experienced the highest price growth at 5%, while USD experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI EAFE ETF (EFA) ETF was 59%. For the same stocks of the ETF, the average monthly volume growth was 37% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 54
Price Growth Rating: 55
SMR Rating: 60
Profit Risk Rating: 62
Seasonality Score: 7 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.